On April 14,  a ceremony of awarding the winners of XXII All-Russian open contest of pharmaceutical industry professionals "Platinum Ounce" took place.

Platinum Ounce nominees and winners were determined by representatives of the scientific community, authoritative publications on the pharmaceutical market, and CEOs of pharmaceutical companies. 

Pharmasyntez received an award in the special category "For National NSAID Segment Development" with the drug Etorelex. 

“Winning the prize in the special nomination means recognition of the company's merits in providing Russian citizens with quality and affordable medicines. The NSAID market is developing and expanding very rapidly. Each of us faces pain, so this group of drugs should be as accessible to the population as possible,” Nadezhda Bystrova, Marketing Director of Pharmasyntez, shared her opinion.